Amdocs Non Current Assets Total vs Cash And Short Term Investments Analysis

DOX Stock  USD 87.37  0.07  0.08%   
Amdocs financial indicator trend analysis is way more than just evaluating Amdocs prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Amdocs is a good investment. Please check the relationship between Amdocs Non Current Assets Total and its Cash And Short Term Investments accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

Non Current Assets Total vs Cash And Short Term Investments

Non Current Assets Total vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Amdocs Non Current Assets Total account and Cash And Short Term Investments. At this time, the significance of the direction appears to have very week relationship.
The correlation between Amdocs' Non Current Assets Total and Cash And Short Term Investments is 0.2. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Amdocs, assuming nothing else is changed. The correlation between historical values of Amdocs' Non Current Assets Total and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Amdocs are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Non Current Assets Total i.e., Amdocs' Non Current Assets Total and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.2
Relationship DirectionPositive 
Relationship StrengthVery Weak

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Amdocs balance sheet. This account contains Amdocs investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Amdocs fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from Amdocs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amdocs current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.At this time, Amdocs' Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 15.40 in 2024, whereas Selling General Administrative is likely to drop slightly above 390.6 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit1.6B1.7B2.0B1.1B
Total Revenue4.6B4.9B5.6B3.1B

Amdocs fundamental ratios Correlations

0.560.510.950.960.650.20.770.050.430.970.750.440.93-0.880.650.73-0.610.940.810.040.950.640.940.530.95
0.560.50.440.490.730.530.76-0.2-0.220.680.67-0.250.67-0.760.610.85-0.770.570.150.110.620.730.630.090.47
0.510.50.370.320.840.770.77-0.43-0.040.590.750.030.37-0.710.850.71-0.820.670.19-0.330.510.840.550.550.5
0.950.440.370.970.48-0.010.690.30.480.880.650.520.92-0.770.470.65-0.460.820.860.130.940.470.920.470.87
0.960.490.320.970.46-0.060.670.280.540.870.640.550.93-0.750.450.66-0.410.80.890.230.920.450.90.380.86
0.650.730.840.480.460.820.93-0.48-0.020.740.90.00.55-0.860.980.87-0.950.790.28-0.320.661.00.70.570.67
0.20.530.77-0.01-0.060.820.6-0.72-0.470.390.57-0.450.13-0.580.790.53-0.840.48-0.28-0.520.20.820.260.410.3
0.770.760.770.690.670.930.6-0.190.10.810.950.160.72-0.90.890.95-0.90.810.49-0.120.820.930.850.540.75
0.05-0.2-0.430.30.28-0.48-0.72-0.190.34-0.11-0.170.430.140.24-0.48-0.10.47-0.20.40.120.11-0.490.07-0.22-0.06
0.43-0.22-0.040.480.54-0.02-0.470.10.340.20.170.960.21-0.030.10.060.240.270.840.140.33-0.030.30.210.31
0.970.680.590.880.870.740.390.81-0.110.20.760.20.93-0.960.710.77-0.740.970.63-0.010.930.730.930.510.94
0.750.670.750.650.640.90.570.95-0.170.170.760.250.66-0.830.90.91-0.820.790.52-0.190.780.90.810.560.77
0.44-0.250.030.520.550.0-0.450.160.430.960.20.250.22-0.050.130.10.190.290.870.050.37-0.010.340.340.37
0.930.670.370.920.930.550.130.720.140.210.930.660.22-0.870.490.74-0.580.830.670.230.930.540.920.340.86
-0.88-0.76-0.71-0.77-0.75-0.86-0.58-0.90.24-0.03-0.96-0.83-0.05-0.87-0.81-0.840.89-0.94-0.480.06-0.89-0.85-0.91-0.53-0.88
0.650.610.850.470.450.980.790.89-0.480.10.710.90.130.49-0.810.8-0.890.810.34-0.40.630.980.670.640.69
0.730.850.710.650.660.870.530.95-0.10.060.770.910.10.74-0.840.8-0.830.720.44-0.050.780.860.80.40.65
-0.61-0.77-0.82-0.46-0.41-0.95-0.84-0.90.470.24-0.74-0.820.19-0.580.89-0.89-0.83-0.76-0.140.25-0.62-0.95-0.67-0.53-0.64
0.940.570.670.820.80.790.480.81-0.20.270.970.790.290.83-0.940.810.72-0.760.64-0.180.880.790.890.640.95
0.810.150.190.860.890.28-0.280.490.40.840.630.520.870.67-0.480.340.44-0.140.640.150.750.260.720.430.72
0.040.11-0.330.130.23-0.32-0.52-0.120.120.14-0.01-0.190.050.230.06-0.4-0.050.25-0.180.150.09-0.320.05-0.41-0.09
0.950.620.510.940.920.660.20.820.110.330.930.780.370.93-0.890.630.78-0.620.880.750.090.651.00.440.89
0.640.730.840.470.451.00.820.93-0.49-0.030.730.9-0.010.54-0.850.980.86-0.950.790.26-0.320.650.690.570.67
0.940.630.550.920.90.70.260.850.070.30.930.810.340.92-0.910.670.8-0.670.890.720.051.00.690.470.91
0.530.090.550.470.380.570.410.54-0.220.210.510.560.340.34-0.530.640.4-0.530.640.43-0.410.440.570.470.63
0.950.470.50.870.860.670.30.75-0.060.310.940.770.370.86-0.880.690.65-0.640.950.72-0.090.890.670.910.63
Click cells to compare fundamentals

Amdocs Account Relationship Matchups

Amdocs fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets6.3B6.5B6.4B6.4B7.4B4.5B
Other Current Liab794.4M851.9M787.1M802.0M922.3M968.4M
Total Current Liabilities1.2B1.3B1.3B1.4B1.6B1.0B
Total Stockholder Equity3.6B3.6B3.5B3.5B4.1B2.8B
Property Plant And Equipment Net903.4M931.9M971.2M951.9M1.1B1.1B
Net Debt50.0M172.1M253.5M287.2M258.5M271.4M
Retained Earnings5.3B5.9B6.2B6.5B7.5B7.9B
Accounts Payable110.1M121.2M134.4M293.3M337.3M394.9M
Cash983.2M709.1M573.4M520.1M598.1M720.1M
Non Current Assets Total4.3B4.4B4.4B4.5B5.2B2.6B
Non Currrent Assets Other488.6M630.7M574.9M631.6M726.3M762.6M
Cash And Short Term Investments983.9M965.6M818.0M742.5M853.9M1.0B
Net Receivables861.0M866.8M946.8M944.5M1.1B618.6M
Common Stock Shares Outstanding133.2M128.0M121.9M118.5M106.6M144.3M
Liabilities And Stockholders Equity6.3B6.5B6.4B6.4B7.4B4.5B
Non Current Liabilities Total1.5B1.6B1.6B1.5B1.7B1.8B
Other Current Assets229.6M235.1M238.4M224.6M258.3M307.0M
Other Stockholder Equity(1.7B)(2.3B)(2.6B)(3.0B)(2.7B)(2.5B)
Total Liab2.7B2.9B2.8B2.9B3.3B1.7B
Total Current Assets2.1B2.1B2.0B1.9B2.2B1.9B
Short Term Debt159.1M58.7M43.3M40.0M46.0M43.7M
Property Plant And Equipment Gross903.4M931.9M971.2M951.9M1.1B1.1B
Accumulated Other Comprehensive Income11.7M9.3M(72.5M)(53.3M)(47.9M)(45.5M)
Common Stock4.5M4.5M4.5M4.6M5.3M4.4M
Current Deferred Revenue126.8M237.4M253.7M170.6M196.2M184.3M
Other Liab542.4M586.2M750.3M793.9M913.0M469.4M
Other Assets423.9M488.6M630.7M574.9M661.2M386.6M
Good Will2.6B2.6B2.7B2.7B3.2B1.9B
Intangible Assets296.3M259.0M178.3M181.5M163.4M317.6M
Property Plant Equipment354.0M723.6M931.9M971.2M1.1B1.2B
Short Term Investments752K256.5M244.6M222.5M200.2M266.3M
Net Tangible Assets660.6M567.8M711.0M676.6M609.0M676.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amdocs Stock Analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.